Your browser doesn't support javascript.
loading
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma.
Wong, Jonathan; Gruber, Emily; Maher, Belinda; Waltham, Mark; Sabouri-Thompson, Zahra; Jong, Ian; Luong, Quinton; Levy, Sidney; Kumar, Beena; Brasacchio, Daniella; Jia, Wendy; So, Joan; Skinner, Hugh; Lewis, Alexander; Hogg, Simon J; Vervoort, Stephin; DiCorleto, Carmen; Uhe, Micheleine; Gamgee, Jeanette; Opat, Stephen; Gregory, Gareth P; Polekhina, Galina; Reynolds, John; Hawkes, Eliza A; Kailainathan, Gajan; Gasiorowski, Robin; Kats, Lev M; Shortt, Jake.
Afiliação
  • Wong J; Monash Haematology, Monash Health, Clayton, VIC, Australia.
  • Gruber E; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Maher B; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
  • Waltham M; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Sabouri-Thompson Z; Monash Haematology, Monash Health, Clayton, VIC, Australia.
  • Jong I; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Luong Q; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Levy S; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Kumar B; Monash Health Imaging, Monash Health, Clayton, VIC, Australia.
  • Brasacchio D; Department of Imaging, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Jia W; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • So J; Monash Health Imaging, Monash Health, Clayton, VIC, Australia.
  • Skinner H; Department of Imaging, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Lewis A; Monash Pathology, Monash Health, Clayton, VIC, Australia.
  • Hogg SJ; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Vervoort S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • DiCorleto C; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Uhe M; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Gamgee J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Opat S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
  • Gregory GP; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Polekhina G; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
  • Reynolds J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Hawkes EA; Monash Haematology, Monash Health, Clayton, VIC, Australia.
  • Kailainathan G; Monash Haematology, Monash Health, Clayton, VIC, Australia.
  • Gasiorowski R; Monash Haematology, Monash Health, Clayton, VIC, Australia.
  • Kats LM; Monash Haematology, Monash Health, Clayton, VIC, Australia.
  • Shortt J; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
Leukemia ; 36(6): 1654-1665, 2022 06.
Article em En | MEDLINE | ID: mdl-35459873

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Linfoma de Células T Periférico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Linfoma de Células T Periférico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article